- $8.16bn
- $11.69bn
- $2.55bn
- 76
- 44
- 55
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,724 | 1,560 | 1,851 | 2,351 | 2,548 |
Cost of Revenue | |||||
Gross Profit | 1,106 | 911 | 1,158 | 1,441 | 1,659 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,338 | 1,652 | 1,509 | 1,881 | 1,971 |
Operating Profit | 386 | -91.7 | 342 | 470 | 577 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 217 | -301 | 204 | 261 | 369 |
Provision for Income Taxes | |||||
Net Income After Taxes | 155 | -280 | 136 | 167 | 267 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 99 | -244 | 0.137 | 201 | 267 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 99 | -244 | 0.137 | 201 | 267 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.71 | -0.018 | 1.42 | 5.54 | 9.69 |